Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
280.65
USD
+0.36 (+0.13%)
Streaming Delayed Price
Updated: 9:05 AM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Biogen Idec
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Apple Sells $8.5 Billion in Bonds to Fuel Share Buybacks
May 05, 2020
Apple paid the lowest in seven years on the bonds that come due in three and five years.
Tags
F
BA
Market News
From
Motley Fool
Apple borrows on the cheap to fund buybacks, dividends
May 04, 2020
Apple Inc on Monday capitalized on the Federal Reserve's emergency measures in response to the coronavirus outbreak to issue its cheapest bonds in years, making it the latest blue-chip company to do so...
Tags
companyNews
From
Reuters: Company News
Why Biogen Shares Fell 6.18% in April
May 04, 2020
A delay in the regulatory submission of Alzheimer’s drug aducanumab weighed on the shares.
Tags
BIIB
Market News
From
Motley Fool
Has Biogen Found the Answer to Treating Alzheimer's?
May 01, 2020
The road to approval for aducanumab is far longer than it appears, if it even exists at all.
Tags
BIIB
LLY
Market News
From
Motley Fool
Next Support Level for Biogen Inc (BIIB) is $295.81
April 30, 2020
Biogen Inc (NASDAQ:BIIB) has opened bearishly below the pivot of $299.93 today and has reached the first level of support at $296.77. Analysts will be watching for a cross...
From
Comtex SmarTrend® News Briefs
IBB, GILD, VRTX, BIIB: ETF Inflow Alert
April 30, 2020
Symbols mentioned in this story: IBB, GILD, VRTX, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Better Buy: Cara Therapeutics vs. Sangamo Therapeutics
April 29, 2020
Which stock wins in a battle between these two clinical-stage biotechs?
Tags
SNY
TAK
SGMO
From
Motley Fool
2.2% Return Seen to Date on SmarTrend Biogen Inc Call (BIIB)
April 29, 2020
SmarTrend identified an Uptrend for Biogen Inc (NASDAQ:BIIB) on October 22nd, 2019 at $298.58. In approximately 6 months, Biogen Inc has returned 2.22% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
Intercontinental Exchange Moves Up In Market Cap Rank, Passing Biogen
April 27, 2020
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Intercontinental Exchange Inc (ICE) has taken over the #110 spot from Biogen Inc (BIIB),...
Tags
Stocks
From
Market News Video
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
April 26, 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. ...
Tags
EBS
PTCT
PRAH
From
Benzinga
Analysts Forecast 13% Upside For The Holdings of TOK
April 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Some Biogen Analysts Unimpressed By Explanation For Aducanumab Filing Delay
April 23, 2020
Biogen Inc (NASDAQ: BIIB) shares shed close to 10% Wednesday following therevelation that the BLAfiling for the ...
Tags
Steven Seedhouse
Carter Gould
Analyst Ratings
From
Benzinga
30 S&P 500 Stocks That Rose In The Crisis: It’s A Market Of Stocks
April 23, 2020
An overview of these 30 risers that have gone against the grain.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
10 Biggest Price Target Changes For Thursday
April 23, 2020
BMO Capital boosted the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $680 to $780. Chipotle closed at $882.26 on ...
Tags
BIIB
Price Target Changes
Analyst Ratings
From
Benzinga
A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings, Economic Reports
April 23, 2020
Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade, ahead of earnings from Eli Lilly and Company (NYSE: ...
Tags
BIIB
UNP
DPZ
From
Benzinga
70 Biggest Movers From Yesterday
April 23, 2020
Gainers SAExploration Holdings, Inc. (NASDAQ: SAEX) shares surged 98.2% to close at $2.22 on Wednesday after the company disclosed ...
Tags
Benzinga
SDC
Application Software
From
Benzinga
Japanese shares snap 3-day losing streak as battered stocks bought back
April 23, 2020
Japanese stocks rose on Thursday, as sellers covered their positions after Wall Street rebounded overnight on the promise of more U.S. government aid to ease the economic damage inflicted by the...
Tags
companyNews
From
Reuters: Company News
Japanese shares rise after 3 days of falls; Eisai slumps on drug delay
April 22, 2020
Japanese stocks rose on Thursday, as sellers covered their positions after Wall Street shares rebounded overnight on the promise of more U.S. government aid to ease the economic pain inflicted by the...
Tags
companyNews
From
Reuters: Company News
Biogen Reports First-Quarter Results, Shares Plunge 9.4%
April 22, 2020
The biotech company announced that its FDA filing of aducanumab, a potential treatment for Alzheimer’s disease, will be delayed.
Tags
ESALY
Market News
BIIB
From
Motley Fool
Biogen Inc (BIIB) Q1 2020 Earnings Call Transcript
April 22, 2020
BIIB earnings call for the period ending March 31, 2020.
Tags
Market News
BIIB
From
Motley Fool
Noteworthy Wednesday Option Activity: CNNE, BIIB, SFNC
April 22, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cannae Holdings Inc (CNNE), where a total volume of 5,008 contracts has been traded...
Tags
Stocks
From
Market News Video
Johnson & Johnson and AbbVie Earn a New FDA Approval for Imbruvica
April 22, 2020
The cancer drug is now approved for 11 different indications.
Tags
Market News
JNJ
ABBV
From
Motley Fool
Why Biogen Stock Is Sinking Today
April 22, 2020
The biotech's Q1 update brought some unwelcome news.
Tags
RHHBY
Market News
BIIB
From
Motley Fool
Shares of Biogen Inc Down on Above Average Volume, Moving Against Trend (BIIB)
April 22, 2020
Biogen Inc's stock is down 10.8% to $293.40 on heavy trading volume. Today's volume of 3.0 million shares tops the average 30-day volume of 2.4 million shares. Unusually...
From
Comtex SmarTrend® News Briefs
Noteworthy ETF Inflows: IBB, VRTX, BIIB, REGN
April 22, 2020
Symbols mentioned in this story: IBB, VRTX, BIIB, REGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
UPDATE 2-Biogen delays Alzheimer's drug filing plans, shares fall 11%
April 22, 2020
Biogen Inc on Wednesday delayed the filing for marketing approval of its experimental Alzheimer's disease drug, saying that it needed more time to prepare the data before submission.
Tags
companyNews
From
Reuters: Company News
Nasdaq 100 Movers: BIIB, LRCX
April 22, 2020
In early trading on Wednesday, shares of Lam Research topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.7%. Year to date, Lam Research has lost about 10.3%...
Tags
Stocks
From
Market News Video
S&P 500 Movers: BIIB, EXPE
April 22, 2020
In early trading on Wednesday, shares of Expedia Group topped the list of the day's best performing components of the S&P 500 index, trading up 8.0%. Year to date, Expedia Group has lost about 42.8% of...
Tags
Stocks
From
Market News Video
Dow Jones Today Poised To Bounce As Oil Prices Wobble; Netflix Dives, Facebook Takes A Stake In India
April 22, 2020
BioNTech soared, Pfizer led the Dow Jones today on vaccine news, as oil prices sought equilibirum amid the coronavirus pandemic.
From
Investor's Business Daily
UPDATE 1-Biogen delays Alzheimer's drug filing plans, shares fall
April 22, 2020
Biogen Inc said on Wednesday it would delay filing for marketing approval of its much-awaited experimental Alzheimer's disease drug to the third quarter, sending its shares down 7%.
Tags
companyNews
From
Reuters: Company News
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.